{"type":"article","show_header_text":true,"header":"ARTICLES ABOUT WILLIAM A. HASELTINE","query":"(per=\"HASELTINE, WILLIAM A\") and tom!=\"Caption\" and tom!=\"Correction\" and tom!=\"List\" and tom!=\"Paid Death Notice\" and dsk!=\"Society\"","search_query":"(persons:\"HASELTINE, WILLIAM A\") AND -type_of_material:\"Caption\" AND -type_of_material:\"Correction\" AND -type_of_material:\"List\" AND -type_of_material:\"Paid Death Notice\" AND -news_desk:\"Society\"","num_search_articles":"10","show_summary":true,"show_byline":true,"show_pub_date":true,"hide_thumbnails":false,"show_kicker":false,"show_title":false,"show_related_topics":true,"show_rad_links":true,"show_subtopics":true,"exclude_topics":"HASELTINE, WILLIAM A","more_on_header":"MORE ON WILLIAM A. HASELTINE AND:","alternate_index_subidx":"","show_thumbnails":true}

William A. Haseltine, the bold-talking chairman and chief executive of Human Genome Sciences, will be leaving the company as it struggles to realize his grand vision of parlaying genetic information into a cornucopia of new drugs. Dr. Haseltine...

Human Genome Sciences has described itself as working at the cutting edge of genomics, outpacing rivals in sifting through thousands of previously unknown human genes to come up with novel drugs. But the company is beginning to look to some analysts...

Regenerative medicine is the concept of repairing the body by developing new tissues and organs as the old ones wear out. The idea, though futuristic, is rooted in practices like growing new skin for burn victims and has acquired new plausibility...

December 18, 2001, Tuesday

A drug developed by a big pharmaceutical company from a pioneering genomics collaboration has entered clinical trials, says William A. Haseltine, the chief executive of Human Genome Sciences. GlaxoSmithKline said Thursday at an analyst meeting in...

February 26, 2001, Monday

What next, a patent on the human heart? No, but a production line for kits so surgeons can build hearts, maybe. William Haseltine, the highflying chief executive of Human Genome Sciences, raised that possibility last week. His company, which aims to...

AT the turn of century, New York Europhiles gloried in apartments with chandeliers. All it took Gale Hayman, the beauty expert, to bring l'atmosphere Baedeker to her apartment on Fifth Avenue was a can of paint, a scattering of good but not priceless...

NO one would ever invite the human genome to a party. It is long winded, highly repetitive and frustratingly full of intriguing stories that it has no idea how to tell in an organized way. Still, the genome has suddenly become hot property. There...

To the Editor: William A. Haseltine (Op-Ed, May 21) argues that the Government should get out of the field of human genome sequencing and ''let private companies and charitable foundations finish the job.'' This would leave the field open for...

To the Editor: An Aug. 7 news article quotes Dr. J. Craig Venter of the Institute for Genomic Research as saying of the work on the genome of the ulcer-causing bacterium Helicobacter pylori, ''we paid for it ourselves and are giving it away for...